VISTAGEN THERAPEUTICS, INC.: 10-Q filed 2012-02-14

Name: VISTAGEN THERAPEUTICS, INC.: 10-Q filed 2012-02-14
Creator: VISTAGEN THERAPEUTICS, INC.

What VISTAGEN THERAPEUTICS, INC. reported in its quarterly report filed 2012-02-14 (fiscal Q3 2011): 30 published measures, 97 facts as tagged in accession 0001415889-12-000216.

This filing

Form: 10-Q (quarterly report)
Filed: 2012-02-14
Fiscal period: fiscal Q3 2011
Accession: 0001415889-12-000216 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All VISTAGEN THERAPEUTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2011-12-31	399,717	USD
At 2011-03-31	323,682	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2011-12-31	5,162,025	USD
At 2011-03-31	18,673,335	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2011-12-31	-4,762,308	USD
At 2011-03-31	-32,884,464	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2011-12-31	166,421	USD
At 2011-03-31	139,343	USD
At 2010-12-31	279,390	USD
At 2010-03-31	200,981	USD
At 1998-05-25	0	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2011-10-01 to 2011-12-31	-4,500,187	USD	92
2011-04-01 to 2011-12-31	-9,167,588	USD	275
1998-05-26 to 2011-12-31	-51,740,566	USD	4968
2010-10-01 to 2010-12-31	-3,392,548	USD	92
2010-04-01 to 2010-12-31	-5,945,878	USD	275

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2011-04-01 to 2011-12-31	-2,847,317	USD	275
1998-05-26 to 2011-12-31	-16,790,003	USD	4968
2010-04-01 to 2010-12-31	-750,885	USD	275

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2011-10-01 to 2011-12-31	2,365	USD	92
2011-04-01 to 2011-12-31	873,269	USD	275
1998-05-26 to 2011-12-31	15,700,934	USD	4968
2010-10-01 to 2010-12-31	584,772	USD	92
2010-04-01 to 2010-12-31	1,718,269	USD	275

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2011-04-01 to 2011-12-31	2,887,759	USD	275
1998-05-26 to 2011-12-31	17,618,174	USD	4968
2010-04-01 to 2010-12-31	887,048	USD	275

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2011-04-01 to 2011-12-31	-13,364	USD	275
1998-05-26 to 2011-12-31	-661,750	USD	4968
2010-04-01 to 2010-12-31	-57,754	USD	275

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2011-12-31	-51,740,566	USD
At 2011-03-31	-42,572,977	USD

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2011-10-01 to 2011-12-31	16,035,861	shares	92
2011-04-01 to 2011-12-31	14,139,007	shares	275
2010-10-01 to 2010-12-31	5,240,110	shares	92
2010-04-01 to 2010-12-31	5,240,110	shares	275

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2011-10-01 to 2011-12-31	-0.28	USD/shares	92
2011-04-01 to 2011-12-31	-0.65	USD/shares	275
2010-10-01 to 2010-12-31	-0.65	USD/shares	92
2010-04-01 to 2010-12-31	-1.13	USD/shares	275

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2011-10-01 to 2011-12-31	0	USD	92
2011-04-01 to 2011-12-31	1,600	USD	275
1998-05-26 to 2011-12-31	16,809	USD	4968
2010-10-01 to 2010-12-31	0	USD	92
2010-04-01 to 2010-12-31	1,600	USD	275

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2011-12-31	86,647	USD
At 2011-03-31	87,728	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2011-04-01 to 2011-12-31	1,447,434	USD	275
1998-05-26 to 2011-12-31	4,210,463	USD	4968
2010-04-01 to 2010-12-31	1,221,916	USD	275

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2011-10-01 to 2011-12-31	-2,851,162	USD	92
2011-04-01 to 2011-12-31	-6,256,860	USD	275
1998-05-26 to 2011-12-31	-41,810,121	USD	4968
2010-10-01 to 2010-12-31	-2,527,149	USD	92
2010-04-01 to 2010-12-31	-3,850,176	USD	275

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2011-12-31	281,926	USD
At 2011-03-31	204,810	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2011-10-01 to 2011-12-31	455,525	USD	92
2011-04-01 to 2011-12-31	1,637,644	USD	275
1998-05-26 to 2011-12-31	9,185,937	USD	4968
2010-10-01 to 2010-12-31	1,009,469	USD	92
2010-04-01 to 2010-12-31	2,251,058	USD	275

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2011-12-31	2,218,167	USD
At 2011-03-31	10,825,686	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2011-12-31	1,041,439	USD
At 2011-03-31	1,767,085	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2011-10-01 to 2011-12-31	2,853,527	USD	92
2011-04-01 to 2011-12-31	7,130,129	USD	275
1998-05-26 to 2011-12-31	57,511,055	USD	4968
2010-10-01 to 2010-12-31	3,111,921	USD	92
2010-04-01 to 2010-12-31	5,568,445	USD	275

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2011-10-01 to 2011-12-31	1,305,585	USD	92
2011-04-01 to 2011-12-31	3,560,999	USD	275
1998-05-26 to 2011-12-31	24,297,267	USD	4968
2010-10-01 to 2010-12-31	446,811	USD	92
2010-04-01 to 2010-12-31	1,813,509	USD	275

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2011-12-31	16,428,648	shares
At 2011-03-31	5,241,110	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2011-12-31	50,691,191	USD
At 2011-03-31	9,867,355	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2011-12-31	31,144	USD
At 2011-03-31	31,144	USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2011-12-31	0	USD
At 2011-03-31	417,054	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2011-12-31	452,832	USD
At 2011-03-31	1,421,906	USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2011-10-01 to 2011-12-31	1,547,942	USD	92
2011-04-01 to 2011-12-31	3,569,130	USD	275
1998-05-26 to 2011-12-31	25,690,609	USD	4968
2010-10-01 to 2010-12-31	2,665,110	USD	92
2010-04-01 to 2010-12-31	3,754,936	USD	275

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2011-04-01 to 2011-12-31	2,528,442	USD	275
1998-05-26 to 2011-12-31	2,649,246	USD	4968
2010-04-01 to 2010-12-31	0	USD	275

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2011-04-01 to 2011-12-31	-34,437	USD	275
1998-05-26 to 2011-12-31	7,779	USD	4968
2010-04-01 to 2010-12-31	8,227	USD	275

Inspect the source

Entity: VISTAGEN THERAPEUTICS, INC. / CIK 0001411685
Captured: 2026-09-20T08:01:56.841Z
SEC response SHA-256: 1d0d09c7b53b173e35f99fba8d3201ca751174b9bb70167acdba04307bebca91

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001411685.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))